Stock listing
gettex:SLZ0 Enveric Biosciences, Inc. Aktie
German listing (gettex) of Enveric Biosciences, Inc. · home listing NASDAQ:ENVB
Follow Enveric Biosciences, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:ENVB
$1.43 USD -0.03 (-2.1%)
Close on Oct 30, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:ENVB
- Day range
- $1.40 – $1.48 USDOct 30, 2026
- Volume
- 11,982 sharesOct 30, 2026
- Market cap
- $6.40M USDAt the close on Oct 30, 2026 · price × 4.48M shares outstanding
- 52-week range
- $1.17 – $13.25 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $125,273 USDMedian day 52,950 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:ENVB · Home | $1.43 USD | -0.03 (-2.1%) | 11,982 | $1.47 | $1.481 | $1.40 | $1.46 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:ENVB · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $1.43 | -0.03 | -2.1% | $1.47 | $1.481 | $1.40 | 11,982 | |
| $1.46 | -0.01 | -0.7% | $1.43 | $1.49 | $1.42 | 27,933 | |
| $1.47 | +0.05 | +3.5% | $1.485 | $1.489 | $1.38 | 19,166 | |
| $1.42 | +0.04 | +2.9% | $1.356 | $1.44 | $1.356 | 56,485 | |
| $1.38 | -0.02 | -1.4% | $1.40 | $1.41 | $1.30 | 29,335 | |
| $1.40 | -0.06 | -4.1% | $1.44 | $1.505 | $1.39 | 33,300 | |
| $1.46 | -0.05 | -3.3% | $1.51 | $1.57 | $1.44 | 35,100 | |
| $1.51 | +0.07 | +4.9% | $1.465 | $1.588 | $1.43 | 84,500 | |
| $1.44 | +0.05 | +3.6% | $1.375 | $1.445 | $1.375 | 31,300 | |
| $1.39 | +0.01 | +0.7% | $1.38 | $1.425 | $1.36 | 31,500 | |
| $1.38 | -0.01 | -0.7% | $1.35 | $1.442 | $1.35 | 22,500 | |
| $1.39 | +0.02 | +1.5% | $1.37 | $1.438 | $1.35 | 21,200 | |
| $1.37 | -0.03 | -2.1% | $1.38 | $1.45 | $1.33 | 162,800 | |
| $1.40 | -0.07 | -4.8% | $1.43 | $1.49 | $1.38 | 102,100 | |
| $1.47 | +0.02 | +1.4% | $1.43 | $1.52 | $1.40 | 114,600 | |
| $1.45 | -0.07 | -4.6% | $1.48 | $1.495 | $1.44 | 50,200 | |
| $1.52 | +0.025 | +1.7% | $1.47 | $1.531 | $1.46 | 64,900 | |
| $1.495 | +0.025 | +1.7% | $1.45 | $1.51 | $1.45 | 41,400 | |
| $1.47 | -0.04 | -2.6% | $1.53 | $1.53 | $1.43 | 51,000 | |
| $1.51 | +0.03 | +2.0% | $1.46 | $1.53 | $1.45 | 54,300 | |
| $1.48 | +0.02 | +1.4% | $1.51 | $1.53 | $1.46 | 72,900 | |
| $1.46 | -0.025 | -1.7% | $1.455 | $1.48 | $1.41 | 83,600 | |
| $1.485 | +0.035 | +2.4% | $1.44 | $1.53 | $1.421 | 57,100 | |
| $1.45 | -0.02 | -1.4% | $1.46 | $1.48 | $1.423 | 45,800 | |
| $1.47 | -0.03 | -2.0% | $1.51 | $1.56 | $1.45 | 54,600 | |
| $1.50 | -0.045 | -2.9% | $1.522 | $1.53 | $1.48 | 38,200 | |
| $1.545 | -0.02 | -1.3% | $1.57 | $1.58 | $1.478 | 84,700 | |
| $1.565 | +0.025 | +1.6% | $1.576 | $1.60 | $1.52 | 113,400 | |
| $1.54 | -0.02 | -1.3% | $1.54 | $1.608 | $1.52 | 46,300 | |
| $1.56 | -0.06 | -3.7% | $1.64 | $1.649 | $1.55 | 51,300 | |
| $1.62 | +0.03 | +1.9% | $1.62 | $1.649 | $1.519 | 158,300 | |
| $1.59 | +0.10 | +6.7% | $1.493 | $1.64 | $1.489 | 169,600 | |
| $1.49 | +0.03 | +2.1% | $1.45 | $1.54 | $1.45 | 51,600 | |
| $1.46 | -0.02 | -1.4% | $1.47 | $1.53 | $1.44 | 75,300 | |
| $1.48 | +0.06 | +4.2% | $1.423 | $1.538 | $1.41 | 104,200 | |
| $1.42 | -0.04 | -2.7% | $1.45 | $1.48 | $1.42 | 38,700 | |
| $1.46 | +0.005 | +0.3% | $1.45 | $1.46 | $1.42 | 11,500 | |
| $1.455 | +0.035 | +2.5% | $1.48 | $1.48 | $1.40 | 29,800 | |
| $1.42 | +0.03 | +2.2% | $1.38 | $1.452 | $1.38 | 51,500 | |
| $1.39 | -0.05 | -3.5% | $1.40 | $1.45 | $1.36 | 56,742 | |
| $1.44 | 0.00 | 0.0% | $1.47 | $1.47 | $1.374 | 42,959 | |
| $1.44 | +0.07 | +5.1% | $1.40 | $1.44 | $1.37 | 21,276 | |
| $1.37 | 0.00 | 0.0% | $1.39 | $1.39 | $1.35 | 20,993 | |
| $1.37 | 0.00 | 0.0% | $1.35 | $1.38 | $1.33 | 38,529 | |
| $1.37 | 0.00 | 0.0% | $1.41 | $1.41 | $1.34 | 22,213 | |
| $1.37 | 0.00 | 0.0% | $1.371 | $1.39 | $1.34 | 36,701 | |
| $1.37 | -0.09 | -6.2% | $1.47 | $1.52 | $1.17 | 403,135 | |
| $1.46 | +0.05 | +3.5% | $1.44 | $1.49 | $1.399 | 64,794 | |
| $1.41 | -0.02 | -1.4% | $1.44 | $1.471 | $1.37 | 58,200 | |
| $1.43 | +0.04 | +2.9% | $1.40 | $1.44 | $1.38 | 89,150 | |
| $1.39 | +0.08 | +6.1% | $1.34 | $1.39 | $1.29 | 132,766 | |
| $1.31 | -0.04 | -3.0% | $1.38 | $1.39 | $1.25 | 177,034 | |
| $1.35 | -0.13 | -8.8% | $1.48 | $1.60 | $1.34 | 689,223 | |
| $1.48 | -0.055 | -3.6% | $1.54 | $1.54 | $1.45 | 51,220 | |
| $1.535 | +0.025 | +1.7% | $1.53 | $1.57 | $1.45 | 56,244 | |
| $1.51 | -0.04 | -2.6% | $1.54 | $1.58 | $1.50 | 42,671 | |
| $1.55 | 0.00 | 0.0% | $1.52 | $1.62 | $1.52 | 55,661 | |
| $1.55 | +0.01 | +0.6% | $1.53 | $1.57 | $1.48 | 34,549 | |
| $1.54 | -0.01 | -0.6% | $1.56 | $1.58 | $1.51 | 25,339 | |
| $1.55 | -0.01 | -0.6% | $1.60 | $1.63 | $1.53 | 49,322 | |
| $1.56 | -0.11 | -6.6% | $1.71 | $1.71 | $1.43 | 262,711 | |
| $1.67 | -0.02 | -1.2% | $1.58 | $1.68 | $1.53 | 414,689 | |
| $1.69 | +0.09 | +5.6% | $1.58 | $1.75 | $1.563 | 147,612 | |
| $1.60 | +0.03 | +1.9% | $1.56 | $1.63 | $1.52 | 85,377 | |
| $1.57 | +0.14 | +9.8% | $1.47 | $1.58 | $1.43 | 78,561 | |
| $1.43 | +0.10 | +7.5% | $1.31 | $1.46 | $1.285 | 68,055 |
- Ticker
- gettex:SLZ0
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- gettex
- Currency
- EUR
What changed lately
Latest news release · Oct 21, 2026
Enveric Biosciences Announces Positive Results from Recently Completed IND-enabling ADMET Studies
Latest deck · Jun 9, 2026
Investor Presentation (June 2026)
Investor deck · 15 slides
Latest news
Enveric Biosciences Announces Positive Results from Recently Completed IND-enabling ADMET Studies
Oct 21, 2026
Closed $1.51 (+4.9%) on Oct 21, 2026
Enveric Biosciences Secures New U.S. Patent Allowance for Next-Generation, Non-Hallucinogenic Mescaline Derivatives in EVM401 Series
Sep 15, 2026
Closed $1.46 (-1.4%) on Sep 15, 2026
Enveric Biosciences to Present at H.C. Wainwright 28th Annual Global Investment Conference
Sep 1, 2026
Closed $1.37 (0.0%) on Sep 1, 2026
Enveric Biosciences Reports Financial Results and Provides Corporate Update for Second Quarter 2026
Aug 14, 2026
Closed $1.48 (-3.6%) on Aug 17, 2026
Enveric Biosciences Reports New Preclinical Data Supporting the Non-Hallucinogenic Profile of Lead Candidate EB-003
Aug 5, 2026
Closed $1.67 (-1.2%) on Aug 5, 2026
Enveric Biosciences Welcomes Final FDA Guidance for Psychedelic Drug Development
Jul 28, 2026
Closed $1.33 (-0.7%) on Jul 28, 2026
Enveric Biosciences Announces Participation in B. Riley Securities Mind, Muscle & Vision Summit
Jun 29, 2026
Closed $1.38 (-2.8%) on Jun 29, 2026
Enveric Biosciences Announces Participation in 2026 BIO International Convention
Jun 16, 2026
Closed $1.37 (-7.4%) on Jun 16, 2026
Enveric Biosciences to Participate in the UBS 3rd Virtual CNS Day
Jun 9, 2026
Closed $1.60 (-8.6%) on Jun 9, 2026
Decks
Investor Presentation (June 2026)
Investor deck · 15 slides · Jun 9, 2026
Investor Presentation (January 2026)
Investor deck · 17 slides · Jan 9, 2026
Investor Presentation (August 2025)
Investor deck · 14 slides · Aug 29, 2025
Investor Presentation (August 2025)
Investor deck · 15 slides · August 2025
Enveric Biosciences, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 32 in the last 12 months · 147 in all · newest Oct 21, 2026 · oldest 2021
- Decks
- 15 decks · latest Jun 9, 2026
Where Enveric Biosciences, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:ENVB · Home listing | NASDAQ | United States | USD |
| BOATS:ENVB | BOATS | United States | USD |
| gettex:SLZ0 · This page | gettex | Germany | EUR |
| Frankfurt:SLZ0 | Frankfurt | Germany | EUR |
| Munich:SLZ0 | Munich | Germany | EUR |
| Stuttgart:SLZ | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about Enveric Biosciences, Inc.